Jane Street’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $474M | Buy |
16,890,900
+452,000
| +3% | +$12M | 0.06% | 213 |
|
|
2025
Q4 | $409M | Buy |
16,438,900
+7,084,300
| +76% | +$179M | 0.06% | 208 |
|
|
2025
Q3 | $238M | Sell |
9,354,600
-1,119,500
| -11% | -$27.6M | 0.04% | 309 |
|
|
2025
Q2 | $254M | Sell |
10,474,100
-511,900
| -5% | -$11.9M | 0.05% | 237 |
|
|
2025
Q1 | $278M | Sell |
10,986,000
-5,562,100
| -34% | -$146M | 0.07% | 164 |
|
|
2024
Q4 | $439M | Sell |
16,548,100
-570,000
| -3% | -$15.5M | 0.1% | 117 |
|
|
2024
Q3 | $495M | Buy |
17,118,100
+5,563,500
| +48% | +$162M | 0.11% | 96 |
|
|
2024
Q2 | $323M | Buy |
11,554,600
+1,919,900
| +20% | +$52.9M | 0.07% | 137 |
|
|
2024
Q1 | $267M | Sell |
9,634,700
-174,100
| -2% | -$4.83M | 0.06% | 169 |
|
|
2023
Q4 | $282M | Buy |
9,808,800
+6,475,100
| +194% | +$196M | 0.07% | 147 |
|
|
2023
Q3 | $111M | Sell |
3,333,700
-1,062,300
| -24% | -$37.6M | 0.04% | 298 |
|
|
2023
Q2 | $161M | Buy |
4,396,000
+1,710,400
| +64% | +$66.6M | 0.05% | 207 |
|
|
2023
Q1 | $110M | Sell |
2,685,600
-923,600
| -26% | -$39.9M | 0.04% | 280 |
|
|
2022
Q4 | $185M | Buy |
3,609,200
+302,600
| +9% | +$14.5M | 0.09% | 152 |
|
|
2022
Q3 | $145M | Sell |
3,306,600
-638,900
| -16% | -$31M | 0.06% | 192 |
|
|
2022
Q2 | $207M | Buy |
3,945,500
+916,500
| +30% | +$46.7M | 0.09% | 144 |
|
|
2022
Q1 | $157M | Buy |
3,029,000
+320,300
| +12% | +$16.6M | 0.05% | 243 |
|
|
2021
Q4 | $160M | Sell |
2,708,700
-208,000
| -7% | -$10.3M | 0.05% | 238 |
|
|
2021
Q3 | $125M | Buy |
2,916,700
+1,481,100
| +103% | +$65.6M | 0.04% | 285 |
|
|
2021
Q2 | $56.2M | Sell |
1,435,600
-12,100
| -0.8% | -$471K | 0.02% | 494 |
|
|
2021
Q1 | $52.5M | Sell |
1,447,700
-532,700
| -27% | -$18.9M | 0.03% | 467 |
|
|
2020
Q4 | $72.9M | Buy |
1,980,400
+747,431
| +61% | +$27.4M | 0.04% | 336 |
|
|
2020
Q3 | $42.9M | Sell |
1,232,969
-40,263
| -3% | -$1.41M | 0.03% | 443 |
|
|
2020
Q2 | $39.5M | Buy |
1,273,232
+13,597
| +1% | +$462K | 0.03% | 433 |
|
|
2020
Q1 | $39M | Buy |
1,259,635
+887,151
| +238% | +$30.2M | 0.04% | 290 |
|
|
2019
Q4 | $13.8M | Sell |
372,484
-168,218
| -31% | -$5.99M | 0.02% | 506 |
|
|
2019
Q3 | $18.4M | Buy |
540,702
+269,297
| +99% | +$9.79M | 0.03% | 378 |
|
|
2019
Q2 | $11.2M | Buy |
271,405
+28,563
| +12% | +$1.13M | 0.02% | 571 |
|
|
2019
Q1 | $9.79M | Buy |
242,842
+166,322
| +217% | +$6.66M | 0.02% | 704 |
|
|
2018
Q4 | $3.17M | Buy |
76,520
+60,288
| +371% | +$2.5M | 0.01% | 1279 |
|
|
2018
Q3 | $679K | Sell |
16,232
-61,342
| -79% | -$2.36M | ﹤0.01% | 3245 |
|
|
2018
Q2 | $2.67M | Buy |
77,574
+9,275
| +14% | +$317K | 0.01% | 1611 |
|
|
2018
Q1 | $2.3M | Buy |
68,299
+8,748
| +15% | +$301K | 0.01% | 1686 |
|
|
2017
Q4 | $2.05M | Sell |
59,551
-30,777
| -34% | -$1.05M | 0.01% | 1575 |
|
|
2017
Q3 | $3.06M | Buy |
90,328
+82,845
| +1,107% | +$2.66M | 0.01% | 1227 |
|
|
2017
Q2 | $238K | Sell |
7,483
-47,957
| -87% | -$1.51M | ﹤0.01% | 3854 |
|
|
2017
Q1 | $1.8M | Sell |
55,440
-237,994
| -81% | -$7.5M | 0.01% | 1477 |
|
|
2016
Q4 | $9.04M | Buy |
293,434
+282,472
| +2,577% | +$8.62M | 0.04% | 397 |
|
|
2016
Q3 | $352K | Sell |
10,962
-177,599
| -94% | -$5.94M | ﹤0.01% | 3134 |
|
|
2016
Q2 | $6.3M | Buy |
188,561
+29,407
| +18% | +$939K | 0.03% | 528 |
|
|
2016
Q1 | $4.48M | Buy |
159,154
+114,675
| +258% | +$3.28M | 0.03% | 625 |
|
|
2015
Q4 | $1.36M | Buy |
44,479
+3,057
| +7% | +$96.2K | 0.01% | 1424 |
|
|
2015
Q3 | $1.23M | Sell |
41,422
-10,751
| -21% | -$345K | 0.01% | 1441 |
|
|
2015
Q2 | $1.66M | Buy |
+52,173
| New | +$1.7M | 0.01% | 1132 |
|
Other funds holding PFE
VCM
VPM
Jane Street's PFE Position: Q1 2026 in Review
Jane Street increased its Pfizer (PFE) stake by 200% in Q1 2026, buying an estimated $33.4M and bringing the position to 1,883,213 shares worth $52.9M. The position accounts for 0.01% of the portfolio, ranked #1020.
Jane Street first reported a position in PFE in Q2 2013 and has held it in 47 quarters since. The position peaked at $260M in Q2 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Jane Street held 1,883,213 shares of Pfizer worth $52.9M as of Q1 2026.
- Jane Street bought 1,255,392 Pfizer shares in Q1 2026, an estimated $33.4M.
- Pfizer made up 0.01% of Jane Street's portfolio in Q1 2026, its #1020 holding.
- Jane Street first reported a position in Pfizer in Q2 2013 and has held it in 47 quarters since.
- Jane Street's Pfizer position peaked at $260M in Q2 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.